Literature DB >> 15365731

[Drug-coated stents. Where do we stand in 2004?].

B Scheller.   

Abstract

Mesh：

Substances：

Year:  2004        PMID： 15365731     DOI： 10.1007/s00392-004-0145-6

Source DB:  PubMed          Journal:  Z Kardiol        ISSN： 0300-5860


× No keyword cloud information.
  22 in total

1.  Late thrombosis after radiation. Sitting on a time bomb.

Authors:  R Waksman
Journal:  Circulation       Date:  1999-08-24       Impact factor: 29.690

2.  Can we afford to eliminate restenosis? Can we afford not to?

Authors:  Dan Greenberg; Ameet Bakhai; David J Cohen
Journal:  J Am Coll Cardiol       Date:  2004-02-18       Impact factor: 24.094

3.  Pathological analysis of local delivery of paclitaxel via a polymer-coated stent.

Authors:  A Farb; P F Heller; S Shroff; L Cheng; F D Kolodgie; A J Carter; D S Scott; J Froehlich; R Virmani
Journal:  Circulation       Date:  2001-07-24       Impact factor: 29.690

4.  A paclitaxel-eluting stent for the prevention of coronary restenosis.

Authors:  Seung-Jung Park; Won Heum Shim; David S Ho; Albert E Raizner; Seong-Wook Park; Myeong-Ki Hong; Cheol Whan Lee; Donghoon Choi; Yangsoo Jang; Ricky Lam; Neil J Weissman; Gary S Mintz
Journal:  N Engl J Med       Date:  2003-04-17       Impact factor: 91.245

5.  Paclitaxel stent coating inhibits neointimal hyperplasia at 4 weeks in a porcine model of coronary restenosis.

Authors:  A W Heldman; L Cheng; G M Jenkins; P F Heller; D W Kim; M Ware; C Nater; R H Hruban; B Rezai; B S Abella; K E Bunge; J L Kinsella; S J Sollott; E G Lakatta; J A Brinker; W L Hunter; J P Froehlich
Journal:  Circulation       Date:  2001-05-08       Impact factor: 29.690

6.  A polymer-based, paclitaxel-eluting stent in patients with coronary artery disease.

Authors:  Gregg W Stone; Stephen G Ellis; David A Cox; James Hermiller; Charles O'Shaughnessy; James Tift Mann; Mark Turco; Ronald Caputo; Patrick Bergin; Joel Greenberg; Jeffrey J Popma; Mary E Russell
Journal:  N Engl J Med       Date:  2004-01-15       Impact factor: 91.245

7.  Marked inflammatory sequelae to implantation of biodegradable and nonbiodegradable polymers in porcine coronary arteries.

Authors:  W J van der Giessen; A M Lincoff; R S Schwartz; H M van Beusekom; P W Serruys; D R Holmes; S G Ellis; E J Topol
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690

8.  A randomized comparison of a sirolimus-eluting stent with a standard stent for coronary revascularization.

Authors:  Marie-Claude Morice; Patrick W Serruys; J Eduardo Sousa; Jean Fajadet; Ernesto Ban Hayashi; Marco Perin; Antonio Colombo; G Schuler; Paul Barragan; Giulio Guagliumi; Ferenc Molnàr; Robert Falotico
Journal:  N Engl J Med       Date:  2002-06-06       Impact factor: 91.245

9.  TAXUS I: six- and twelve-month results from a randomized, double-blind trial on a slow-release paclitaxel-eluting stent for de novo coronary lesions.

Authors:  Eberhard Grube; Sigmund Silber; Karl Eugen Hauptmann; Ralf Mueller; Lutz Buellesfeld; Ulrich Gerckens; Mary E Russell
Journal:  Circulation       Date:  2003-01-07       Impact factor: 29.690

10.  Inhibition of restenosis with a paclitaxel-eluting, polymer-free coronary stent: the European evaLUation of pacliTaxel Eluting Stent (ELUTES) trial.

Authors:  Anthony Gershlick; Ivan De Scheerder; Bernard Chevalier; Amanda Stephens-Lloyd; Edoardo Camenzind; Christian Vrints; Nicolaus Reifart; Luc Missault; Jean-Jacques Goy; Jeffrey A Brinker; Albert E Raizner; Philip Urban; Alan W Heldman
Journal:  Circulation       Date:  2004-01-26       Impact factor: 29.690
View more
  1 in total

1.  The Sirolimus-eluting coronary stent in daily routine practice in Germany: trends in indications over the years. Results from the prospective multi-centre German Cypher Stent Registry.

Authors:  Ralf Zahn; C W Hamm; S Schneider; U Zeymer; G Richardt; M Kelm; B Levenson; T Bonzel; U Tebbe; G Sabin; C A Nienaber; Thomas Pfannebecker; J Senges
Journal:  Clin Res Cardiol       Date:  2007-06-04       Impact factor: 5.460
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.